Detection of anti-Aquaporin-4 antibodies in neuromyelitis optica: Current status of the assays

International MS Journal

Volumn 15, Issue 3, 2008, Pages 99-105

  Waters, P ^a   Vincent, A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Assay; Immunoprecipitation; Indirect immunofluorescence; Multiple Sclerosis; Neuromyelitis optica; Optic neuritis; Sj gren's syndrome; Transverse myelitis

Indexed keywords

AQUAPORIN 4 ANTIBODY; IMMUNOGLOBULIN G; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; AQP4 PROTEIN, HUMAN; AQUAPORIN 4; AUTOANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; CELL ASSAY; CELL STRAIN HEK293; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ANALYSIS; FLUOROIMMUNOASSAY; HIGH RISK PATIENT; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; INTERMETHOD COMPARISON; MYELITIS; MYELOOPTIC NEUROPATHY; NONHUMAN; OPTIC NEURITIS; PROTEIN LOCALIZATION; RADIOIMMUNOPRECIPITATION; REVIEW; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SPINAL CORD DISEASE; BLOOD; CELL LINE; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; OPTIC NERVE; SPINAL CORD;

AQUAPORIN 4; AUTOANTIBODIES; CELL LINE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOPRECIPITATION; MICROSCOPY, FLUORESCENCE; NEUROMYELITIS OPTICA; OPTIC NERVE; SPINAL CORD; TRANSFECTION;

EID: 56149110659     PISSN: 13528963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Hiroaki Y, Tani K, Kamegawa A, et al. Implications of the aquaporin-A structure on array formation and cell adhesion. J Mol Biol 2006; 355: 628-639.
2. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-477.
3. Weinsnenker BG, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006; 59: 566-569.
4. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 805-815.
5. Wingerchuk DM, Pittock SJ, Lucchinetti CF, et al. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology 2007; 68: 603-605.
6. Pittock SJ, Lennon VA, de Seze J, et al. Neuromyelitis optica and non-organ specific autoimmunity. Arch Neurol 2008 65: 78-83.
7. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.
8. Takahashi T, Fujihara K, Nakashima I, et al. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med 2006; 210: 307-313.
9. Takahashi T, Fujihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007; 130: 1235-1243.
10. Waters P, Jorius S, Littleton E, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally-extensive transverse myelitis. Arch Neurol 2007; 65: 913-919.
11. Paul F, Jarius S, Aktas O, et al. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med 2007; 4: e133.
12. Hayakawa S, Mori M, Okuta A, et al. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol 2008; 196: 181-187.
13. Matiello M, Lennon VA, Jacob A, et al. NMo-Ig predicts the outcome of recurrent optic neuritis. Neurology 2008: [in press].
14. Jarius S, Franciotta D, Bergamaschi R, et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 2007; 68: 1076-1077.
15. Furman CS, Gorelick-Feldman DA, Davidson KG, et al. Aquaporin-4 square array assembly: opposing actions of M1 and M23 isoforms. Proc Natl Acad Sci U S A 2003; 100: 13609-13614.
16. Rash JE, Davidson KG, Yasumura T, Furman CS. Freeze-fracture and immunogold analysis of aquaporin-4 (AQP4) square arrays, with models of AQP4 lattice assembly. Neuroscience 2004; 129: 915-934.
17. Rash JE, Yasumura T, Hudson CS, et al. Direct immunogold labeling of aquaporin-A in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord. Proc Natl Acad Sci U S A 1998; 95: 11981-11986.
18. Jarius S, Paul F, Franciotta D, et al. Aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol. 2008 4(4): 202-214.
19. Leite MI, et al. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain 2008; 131: 1940-1952.
20. Humphreys W, Dolke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996; 14: 33-38.
21. Moe SE, Sorbo JG, Sogaard R, et al. New isoforms of rat Aquaporin-4. Genomics 2008; 91: 367-377.
22. Guex N, Peitsch MC. Swiss model and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis 1997; 18: 2714-2723.
23. Clark, M. Antibody Engineering IgG Effector Mechanisms. Chemical Immunol 1997; 65: 88-110.
24. Marignier R, De Sèze J, Vukusic S, et al. NMO-IgG and Devic's neuromyelitis optica: a French experience. Mult Scler. 2008; 14: 440-445.
25. Saiz A, Zuliani L, Blanco Y, et al; Spanish-Italian NMO Study Group. Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients. J Neurol. 2007; 254(9): 1233-127.